These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
270 related articles for article (PubMed ID: 10362535)
1. Human estrogenic 17beta-hydroxysteroid dehydrogenase: predominance of estrone reduction and its induction by NADPH. Jin JZ; Lin SX Biochem Biophys Res Commun; 1999 Jun; 259(2):489-93. PubMed ID: 10362535 [TBL] [Abstract][Full Text] [Related]
2. Human oestrogenic 17beta-hydroxysteroid dehydrogenase specificity: enzyme regulation through an NADPH-dependent substrate inhibition towards the highly specific oestrone reduction. Gangloff A; Garneau A; Huang YW; Yang F; Lin SX Biochem J; 2001 May; 356(Pt 1):269-76. PubMed ID: 11336660 [TBL] [Abstract][Full Text] [Related]
3. At5g50600 encodes a member of the short-chain dehydrogenase reductase superfamily with 11beta- and 17beta-hydroxysteroid dehydrogenase activities associated with Arabidopsis thaliana seed oil bodies. d'Andréa S; Canonge M; Beopoulos A; Jolivet P; Hartmann MA; Miquel M; Lepiniec L; Chardot T Biochimie; 2007 Feb; 89(2):222-9. PubMed ID: 17074428 [TBL] [Abstract][Full Text] [Related]
4. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone. Laplante Y; Cadot C; Fournier MA; Poirier D Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543 [TBL] [Abstract][Full Text] [Related]
5. Characterisation of estrogenic 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity in the human brain. Steckelbroeck S; Watzka M; Reissinger A; Wegener-Toper P; Bidlingmaier F; Bliesener N; Hans VH; Clusmann H; Ludwig M; Siekmann L; Klingmüller D J Steroid Biochem Mol Biol; 2003 Jul; 86(1):79-92. PubMed ID: 12943747 [TBL] [Abstract][Full Text] [Related]
6. Biochemical factors governing the steady-state estrone/estradiol ratios catalyzed by human 17beta-hydroxysteroid dehydrogenases types 1 and 2 in HEK-293 cells. Sherbet DP; Guryev OL; Papari-Zareei M; Mizrachi D; Rambally S; Akbar S; Auchus RJ Endocrinology; 2009 Sep; 150(9):4154-62. PubMed ID: 19556422 [TBL] [Abstract][Full Text] [Related]
7. Gender differences of enzymatic activity and distribution of 17beta-hydroxysteroid dehydrogenase in human skin in vitro. Hikima T; Maibach HI Skin Pharmacol Physiol; 2007; 20(4):168-74. PubMed ID: 17396051 [TBL] [Abstract][Full Text] [Related]
8. Crystal structures of human 17β-hydroxysteroid dehydrogenase type 1 complexed with estrone and NADP Li T; Stephen P; Zhu DW; Shi R; Lin SX FEBS J; 2019 Jun; 286(11):2155-2166. PubMed ID: 30768851 [TBL] [Abstract][Full Text] [Related]
9. Reactivation of human placental 17 beta,20 alpha-hydroxysteroid dehydrogenase affinity alkylated by estrone 3-(bromoacetate): topographic studies with 16 alpha-(bromoacetoxy)estradiol 3-(methyl ether). Thomas JL; LaRochelle MC; Asibey-Berko E; Strickler RC Biochemistry; 1985 Sep; 24(20):5361-7. PubMed ID: 3865689 [TBL] [Abstract][Full Text] [Related]
10. Focused libraries of 16-substituted estrone derivatives and modified e-ring steroids: inhibitors of 17beta-hydroxysteroid dehydrogenase type 1. Vicker N; Lawrence HR; Allan GM; Bubert C; Smith A; Tutill HJ; Purohit A; Day JM; Mahon MF; Reed MJ; Potter BV ChemMedChem; 2006 Apr; 1(4):464-81. PubMed ID: 16892382 [TBL] [Abstract][Full Text] [Related]
11. The structure of a complex of human 17beta-hydroxysteroid dehydrogenase with estradiol and NADP+ identifies two principal targets for the design of inhibitors. Breton R; Housset D; Mazza C; Fontecilla-Camps JC Structure; 1996 Aug; 4(8):905-15. PubMed ID: 8805577 [TBL] [Abstract][Full Text] [Related]
12. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone. Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590 [TBL] [Abstract][Full Text] [Related]
13. Pseudo-symmetry of C19 steroids, alternative binding orientations, and multispecificity in human estrogenic 17beta-hydroxysteroid dehydrogenase. Gangloff A; Shi R; Nahoum V; Lin SX FASEB J; 2003 Feb; 17(2):274-6. PubMed ID: 12490543 [TBL] [Abstract][Full Text] [Related]
14. Secretory expression, purification and functional characterization of 17β-hydroxysteroid dehydrogenase type 1 from mammalian HEK293T cells. Chen J; Feng W; Zhao Y Protein Expr Purif; 2017 Sep; 137():52-57. PubMed ID: 28669870 [TBL] [Abstract][Full Text] [Related]
15. Critical residues for the specificity of cofactors and substrates in human estrogenic 17beta-hydroxysteroid dehydrogenase 1: variants designed from the three-dimensional structure of the enzyme. Huang YW; Pineau I; Chang HJ; Azzi A; Bellemare V; Laberge S; Lin SX Mol Endocrinol; 2001 Nov; 15(11):2010-20. PubMed ID: 11682630 [TBL] [Abstract][Full Text] [Related]
16. The dual sex hormone specificity for human reductive 17β-hydroxysteroid dehydrogenase type 7: Synergistic function in estrogen and androgen control. Thériault JF; Lin SX J Steroid Biochem Mol Biol; 2019 Feb; 186():61-65. PubMed ID: 30227243 [TBL] [Abstract][Full Text] [Related]
17. New insights into the substrate inhibition of human 17β-hydroxysteroid dehydrogenase type 1. Li T; Song X; Stephen P; Yin H; Lin SX J Steroid Biochem Mol Biol; 2023 Apr; 228():106246. PubMed ID: 36634828 [TBL] [Abstract][Full Text] [Related]
18. Effect of NADH-X on cytosolic glycerol-3-phosphate dehydrogenase. Prabhakar P; Laboy JI; Wang J; Budker T; Din ZZ; Chobanian M; Fahien LA Arch Biochem Biophys; 1998 Dec; 360(2):195-205. PubMed ID: 9851831 [TBL] [Abstract][Full Text] [Related]
19. Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5. Lin SX; Shi R; Qiu W; Azzi A; Zhu DW; Dabbagh HA; Zhou M Mol Cell Endocrinol; 2006 Mar; 248(1-2):38-46. PubMed ID: 16480815 [TBL] [Abstract][Full Text] [Related]
20. [NAD(NADP)-dependent glyceraldehyde 3-phosphate dehydrogenase from Chlorella. Kinetics of inhibition by the reaction products NAD and NADP]. Tomova NG; Krysteva NG; Georgieva MA Biokhimiia; 1981 Oct; 46(10):1748-53. PubMed ID: 7306593 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]